Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
0.3000
-0.1120 (-27.18%)
At close: Apr 2, 2025, 4:00 PM
0.2590
-0.0410 (-13.67%)
After-hours: Apr 2, 2025, 7:59 PM EDT

Processa Pharmaceuticals Stock Forecast

PCSA's stock price has decreased by -87.23% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Processa Pharmaceuticals stock has a target of 6.00, which predicts an increase of 1,900.00% from the current stock price of 0.30.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $6.00 $6.00 $6.00 $6.00
Change +1900.0% +1900.0% +1900.0% +1900.0%
* Price targets were last updated on Dec 5, 2024.

Analyst Ratings

According to 1 stock analyst, the rating for Processa Pharmaceuticals is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Oct '24Nov '24Dec '24Jan '25Feb '25Mar '25
Strong Buy 111111
Buy 111110
Hold 110000
Sell 000000
Strong Sell 000000
Total 332221

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$6
Strong Buy Reiterates $6 +1,900.00% Dec 5, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$6
Strong Buy Reiterates $6 +1,900.00% Oct 3, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$6
Strong Buy Reiterates $6 +1,900.00% Aug 20, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$8$6
Strong Buy Maintains $8$6 +1,900.00% Aug 19, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$8
Strong Buy Reiterates $8 +2,566.67% Aug 1, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.20
from -3.87
EPS Next Year
-6.32
from -2.20
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2028 FY 2029
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2028 Dec 31, 2029
Revenue
--54.14M126.39M
Revenue Growth
---133.46%----
EPS
-50.77-14.92-34.05-8.48-3.87-2.20-6.32-
EPS Growth
--------
Forward PE
--------
No. Analysts -----333
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 2025202620282029
High n/an/a55.7M
Avg n/an/a54.1M
Low n/an/a52.0M

Revenue Growth

Revenue Growth 2025202620282029
High ---
Avg ---
Low ---

EPS Forecast

EPS 20252026
High -2.27-6.51
Avg -2.20-6.32
Low -2.12-6.08

EPS Growth

EPS Growth 20252026
High --
Avg --
Low --
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.